Next Article in Journal
In Vitro Digestion of Grape Seed Oil Inhibits Phospholipid-Regulating Effects of Oxidized Lipids
Next Article in Special Issue
The Hippo Pathway in Cardiac Regeneration and Homeostasis: New Perspectives for Cell-Free Therapy in the Injured Heart
Previous Article in Journal
BAMBI and CHGA in Prion Diseases: Neuropathological Assessment and Potential Role as Disease Biomarkers
Previous Article in Special Issue
Reviewing the Limitations of Adult Mammalian Cardiac Regeneration: Noncoding RNAs as Regulators of Cardiomyogenesis
Review

Novel Applications of Mesenchymal Stem Cell-Derived Exosomes for Myocardial Infarction Therapeutics

1
National Heart and Lung Institute, Imperial College London, London W12 0NN, UK
2
Botucatu Medical School, Sao Paulo State University, Botucatu 18618687, Brazil
*
Authors to whom correspondence should be addressed.
Biomolecules 2020, 10(5), 707; https://doi.org/10.3390/biom10050707
Received: 1 April 2020 / Revised: 22 April 2020 / Accepted: 27 April 2020 / Published: 2 May 2020
Cardiovascular diseases (CVDs) are the leading cause of mortality and morbidity globally, representing approximately a third of all deaths every year. The greater part of these cases is represented by myocardial infarction (MI), or heart attack as it is better known, which occurs when declining blood flow to the heart causes injury to cardiac tissue. Mesenchymal stem cells (MSCs) are multipotent stem cells that represent a promising vector for cell therapies that aim to treat MI due to their potent regenerative effects. However, it remains unclear the extent to which MSC-based therapies are able to induce regeneration in the heart and even less clear the degree to which clinical outcomes could be improved. Exosomes, which are small extracellular vesicles (EVs) known to have implications in intracellular communication, derived from MSCs (MSC-Exos), have recently emerged as a novel cell-free vector that is capable of conferring cardio-protection and regeneration in target cardiac cells. In this review, we assess the current state of research of MSC-Exos in the context of MI. In particular, we place emphasis on the mechanisms of action by which MSC-Exos accomplish their therapeutic effects, along with commentary on the current difficulties faced with exosome research and the ongoing clinical applications of stem-cell derived exosomes in different medical contexts. View Full-Text
Keywords: myocardial infarction; cardiovascular disease; mesenchymal stem cells; exosomes; extracellular vesicles; cardioprotection; cardiac regeneration; cell-free therapy myocardial infarction; cardiovascular disease; mesenchymal stem cells; exosomes; extracellular vesicles; cardioprotection; cardiac regeneration; cell-free therapy
Show Figures

Figure 1

MDPI and ACS Style

Ozaki Tan, S.J.; Floriano, J.F.; Nicastro, L.; Emanueli, C.; Catapano, F. Novel Applications of Mesenchymal Stem Cell-Derived Exosomes for Myocardial Infarction Therapeutics. Biomolecules 2020, 10, 707. https://doi.org/10.3390/biom10050707

AMA Style

Ozaki Tan SJ, Floriano JF, Nicastro L, Emanueli C, Catapano F. Novel Applications of Mesenchymal Stem Cell-Derived Exosomes for Myocardial Infarction Therapeutics. Biomolecules. 2020; 10(5):707. https://doi.org/10.3390/biom10050707

Chicago/Turabian Style

Ozaki Tan, Sho J., Juliana F. Floriano, Laura Nicastro, Costanza Emanueli, and Francesco Catapano. 2020. "Novel Applications of Mesenchymal Stem Cell-Derived Exosomes for Myocardial Infarction Therapeutics" Biomolecules 10, no. 5: 707. https://doi.org/10.3390/biom10050707

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop